Central venous catheters (CVC) are often used in unstable patients for monitoring, resuscitation and delivery of drugs in a life-threatening situation. In these scenarios, the small risks of the CVC are clearly outweighed by the immediate advantages. The delivery of parenteral nutrition (PN) via a CVC is less immediately life-saving and so the risks must be more clearly assessed and minimised. A local revision of elective CVC placement protocol led to a change in practice in 2006. This limited who and where CVCs were placed and managed. This change in protocol was subsequently ratified in the epic2 guidelines (1) .
The average length of use per CVC was 11.6 days. Overall 69 % of CVC were used until the patient completed PN and either restarted oral feeding or an alternative feeding route and 18 % of patients died. The majority of the rest of the CVC were either removed for suspected CRBSI or accidentally. Only 25 % of CVCs were used for less than 5 days of PN. The commonest reasons for termination of feeding in this group were "end of treatment" (44%), alternative feeding route (20%) and died (19 %).
Complications of CVC insertion were rare. CRBSI occurred in 6.5% and half the time was not suspected. The peak incidence of CRBSI was 5-9 days after insertion Table 1 . This peak may imply other factors than routine handling of CVC's are causative. This may include the nature of the insertion or the clinical state of the patient in the first 10 days (i.e. bacteraemia). There has been a marked shift in who and where the CVCs have been inserted but without any obvious effect on CRBSI rates Table 2 . In view of this lack of response, additional measures such as chlorhexidine impregnated CVC's and a chlorhexidine impregnated patch dressing are being introduced to the Trust.
